LPCN 1148 is an oral prodrug of bioidentical testosterone containing testosterone dodecanoate, an androgen receptor agonist.

Sarcopenia is believed to be associated with a poorer prognosis in patients with cirrhosis. Objective: To evaluate the impact of sarcopenia on the prognosis of patients hospitalized for acute ...

Liver cirrhosis was observed in 24.8% of patients. Outcomes included HCC, decompensation, and LT or death, and the mean follow-up was 34.8 months. These findings suggest the potential of TAF ...

Therefore, the aim of the present pilot study was to investigate the feasibility of repetitive SSM and its clinical usefulness after initiation of recompensation measures in patients with cirrhosis ...

additional follow-up data are needed before a recommendation can be made regarding the need to continue lamivudine after initiation of adefovir in patients with decompensated HBV-cirrhosis.